A biomarker test identified tau pathology in Alzheimer's disease before fibrillary tangles developed. Neurofibrillary tangle formation can be prevented by targeting intermediate soluble tau assemblies ...

MIT chemists used NMR spectroscopy to reveal the disordered “fuzzy coat” surrounding Tau protein fibrils, offering new ...

One of the hallmarks of Alzheimer's disease is the clumping of proteins called Tau, which form tangled fibrils in the brain.

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the University of Pittsburgh School of Medicine can detect small amounts of the ...

Following the hard-won success of early anti-amyloid drugs, a new generation of Alzheimer’s modalities—from tau-targeting ...

With two new treatments for Alzheimer’s disease approved in recent years, there’s growing hope for people at risk of the memory-robbing condition. But tests to detect the condition still lag behind.

Alzheimer's disease often begins many years before memory problems appear. During that silent phase, toxic changes slowly build inside the brain. For decades, scientists focused mostly on amyloid ...

There are currently a few tests, including blood tests, that can be used to help diagnose Alzheimer’s and determine which stage the disease is in. Researchers at WashU Medicine have developed a blood ...

Besides memory loss, many people with AD also lose their sensitivity to touch. A new study attributes this to a surprising source: neurofibrillary tangles within the spinal cord. In Nature ...

FRIDAY, April 4, 2025 (HealthDay News) -- An experimental blood test for Alzheimer’s disease not only can aid in its diagnosis but also indicate how far the brain condition has progressed, a new study ...

NEWYou can now listen to Fox News articles! Several blood tests have been shown to accurately diagnose Alzheimer’s disease — as previously reported by Fox News Digital — but now a new test has emerged ...